- Of the three COVID-19 vaccines being tried in India, two are indigenous
- Vaccines by Zydus Cadila and Bharat Biotech have completed phase-I trials
- Results of phase-I are being analysed; recruitment for phase-II has started
New Delhi: Three COVID-19 vaccines are at a clinical trial stage in the country and two indigenous vaccine candidates have completed phase one trial, Indian Council of Medical Research (ICMR) DG Dr Balram Bhargava said on Tuesday (September 15). “Three vaccines are at the clinical trial stage in India. Zydus Cadila and Bharat Biotech have completed phase-I trials. Results are being analysed. They have started recruitment for the second phase,” Dr Bhargava said at a press conference here.
He was replying to a question on the status of COVID-19 vaccines in the country.
Also Read: Serum Institute To Resume COVID-19 Vaccine Trials In India After Nod From Drugs Controller General Of India
Serum Institute of India (SII) has completed phase II-B3 trials. They took seven days break and will start phase-III trial (with 1,500 patients at 14 locations) after clearances, he added.
The Drugs Controller General of India (DCGI) had asked SII to suspend any new recruitment in phase 2 and 3 clinical trials for the COVID-19 vaccine till further orders after reports from AstraZeneca that it had paused the ongoing trial of nCoV19 coronavirus vaccine (recombinant) as a volunteer developed an unexplained illness.
AstraZeneca, which has partnered with Oxford University for development of the vaccine, has since resumed trials in UK.
There is yet no specific drug and vaccine available yet for coronavirus. Dr Bhargava had said that four factors would need to be considered once India has a safe and effective vaccine against coronavirus – priority and fair distribution of the vaccine, logistics and roll out in a cold chain, stockpiling and training of people who are to be given this vaccine.
He said India has been rolling out other vaccines for many years and has the requisite know-how.
Experts say a sustained behavioural change is required at least till there is a safe and effective vaccine. This includes wearing a mask, proper hand hygiene and physical distancing.
India’s COVID-19 case count crossed the 49-lakh mark on Tuesday. A total of 49,30,237 cases have been reported in the country including 9,90,061 active cases, 38,59,400 cured/discharged/migrated patients and 80,776 deaths.
Also Read: COVID-19 Vaccine Roundup: Trials Of Oxford Vaccine Candidate, A Frontrunner In The Global Race, Are Paused After Unexplained Illness Occurred In A Volunteer
(Except for the headline, this story has not been edited by NDTV staff and is published from a syndicated feed.)
NDTV – Dettol Banega Swasth India campaign is an extension of the five-year-old Banega Swachh India initiative helmed by Campaign Ambassador Amitabh Bachchan. It aims to spread awareness about critical health issues facing the country. In wake of the current COVID-19 pandemic, the need for WASH (Water, Sanitation and Hygiene) is reaffirmed as handwashing is one of the ways to prevent Coronavirus infection and other diseases. The campaign highlights the importance of nutrition and healthcare for women and children to prevent maternal and child mortality, fight malnutrition, stunting, wasting, anaemia and disease prevention through vaccines. Importance of programmes like Public Distribution System (PDS), Mid-day Meal Scheme, POSHAN Abhiyan and the role of Aganwadis and ASHA workers are also covered. Only a Swachh or clean India where toilets are used and open defecation free (ODF) status achieved as part of the Swachh Bharat Abhiyan launched by Prime Minister Narendra Modi in 2014, can eradicate diseases like diahorrea and become a Swasth or healthy India. The campaign will continue to cover issues like air pollution, waste management, plastic ban, manual scavenging and sanitation workers and menstrual hygiene.